Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.

Stocks | Futures | Watchlist | More
or

Gamida Cell Ltd (GMDA)

Gamida Cell Ltd (GMDA)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
Quote Overview for [[ item.sessionDateDisplayLong ]]
[[ rowChartData.labelLow ]]
[[ rowChartData.lowPriceFormatted ]]
[[ rowChartData.lowPrice ]]
[[ rowChartData.labelHigh ]]
[[ rowChartData.highPriceFormatted ]]
[[ rowChartData.highPrice ]]
since [[ rowChartData.lowDate ]]
since [[ rowChartData.highDate ]]
[[ value ]] [[ value ]]
Realtime quote and/or trades are not sourced from all markets.

Fundamentals

See More
  • Market Capitalization, $K 155,977
  • Shares Outstanding, K 24,220
  • Annual Sales, $ 0 K
  • Annual Income, $ -72,700 K
  • 60-Month Beta 1.93
  • Price/Sales N/A
  • Price/Cash Flow N/A
  • Price/Book 2.63
Trade GMDA with:

Options Overview

Details
  • Implied Volatility 96.74%
  • Historical Volatility 43.88%
  • IV Percentile 16%
  • IV Rank 15.03%
  • IV High 198.82% on 01/27/21
  • IV Low 78.68% on 04/09/21
  • Put/Call Vol Ratio 0.00
  • Today's Volume 1
  • Volume Avg (30-Day) 35
  • Put/Call OI Ratio 0.18
  • Today's Open Interest 7,632
  • Open Int (30-Day) 7,463

Analyst Rating / Earnings Estimates

Current Rating
See More
Strong Buy
Based on 4 analysts offering recommendations.
Earnings Estimates - Current Qtr 06/30/21
See More
  • Average Estimate -0.38
  • Number of Estimates 3
  • High Estimate -0.35
  • Low Estimate -0.42
  • Prior Year -0.37
  • Growth Rate Est. (year over year) -2.70%

Price Performance

See More
Period Period Low Period High Performance
1-Month
5.76 +11.81%
on 05/25/21
7.09 -9.17%
on 05/12/21
-0.40 (-5.85%)
since 05/11/21
3-Month
5.76 +11.81%
on 05/25/21
9.37 -31.25%
on 03/15/21
-2.51 (-28.04%)
since 03/11/21
52-Week
3.86 +66.84%
on 07/29/20
15.00 -57.07%
on 02/10/21
+1.79 (+38.49%)
since 06/11/20

Most Recent Stories

More News
Gamida Cell: Q1 Earnings Snapshot

JERUSALEM (AP) _ Gamida Cell Ltd. (GMDA) on Tuesday reported a loss of $18 million in its first quarter.

GMDA : 6.44 (-2.13%)
New Strong Sell Stocks for April 26th

ARR, GMDA, ISEE, LMB, and LIQT have been added to the Zacks Rank #5 (Strong Sell) List on April 26, 2021

LIQT : 7.33 (-0.27%)
ARR : 12.00 (-1.07%)
LMB : 9.62 (+1.16%)
GMDA : 6.44 (-2.13%)
ISEE : 6.29 (-3.82%)
Thinking about buying stock in Gamida Cell, Co-Diagnostics, T2 Biosystems, FSD Pharma, or Allena Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for GMDA, CODX, TTOO, HUGE, and ALNA.

ALNA : 1.2700 (+2.42%)
GMDA : 6.44 (-2.13%)
HUGE : 1.9400 (-0.51%)
TTOO : 1.4000 (+1.45%)
CODX : 8.83 (+0.34%)
Thinking about buying stock in Sundial Growers, Neptune Wellness Solutions, Gamida Cell, FSD Pharma, or Salarius Pharmaceuticals?

, /PRNewswire/ -- InvestorsObserver issues critical PriceWatch Alerts for SNDL, NEPT, GMDA, HUGE, and SLRX.

GMDA : 6.44 (-2.13%)
HUGE : 1.9400 (-0.51%)
SLRX : 1.1700 (+1.74%)
SNDL : 1.0500 (+1.94%)
NEPT : 1.4500 (-0.68%)
Gamida Cell: 3Q Earnings Snapshot

JERUSALEM (AP) _ Gamida Cell Ltd. (GMDA) on Tuesday reported a loss of $14.8 million in its third quarter.

GMDA : 6.44 (-2.13%)
Gamida Cell (GMDA) Jumps: Stock Rises 8.4%

Gamida Cell (GMDA) saw a big move last session, as its shares jumped more than 8% on the day, amid huge volumes.

EBS : 63.51 (-3.01%)
GMDA : 6.44 (-2.13%)
Company News for Oct 7, 2020

Companies in the news are: KNSA, GMDA, BNTX, NAKD

NAKD : 0.7470 (+4.50%)
KNSA : 14.86 (+0.20%)
GMDA : 6.44 (-2.13%)
BNTX : 238.55 (-0.53%)
Gamida Cell: 2Q Earnings Snapshot

JERUSALEM (AP) _ Gamida Cell Ltd. (GMDA) on Tuesday reported a second-quarter loss of $14.9 million, after reporting a profit in the same period a year earlier.

GMDA : 6.44 (-2.13%)
Ovid Therapeutics (OVID) Jumps: Stock Rises 12.4%

Ovid Therapeutics (OVID) saw a big move last session, as its shares jumped more than 12% on the day, amid huge volumes.

OVID : 4.49 (+0.67%)
GMDA : 6.44 (-2.13%)
Gamida Cell (GMDA) Upgraded to Strong Buy: Here's Why

Gamida Cell (GMDA) has been upgraded to a Zacks Rank #1 (Strong Buy), reflecting growing optimism about the company's earnings prospects. This might drive the stock higher in the near term.

GMDA : 6.44 (-2.13%)

Barchart Technical Opinion

The Barchart Technical Opinion rating is a 72% Sell with a Strengthening short term outlook on maintaining the current direction.

See More Share

Business Summary

Gamida Cell Ltd. is a biopharmaceutical company. It focuses on developing cell therapies to cure cancer and rare and serious hematologic diseases. The company's product pipeline consists of NiCord and NAM-NK which are in clinical stage. It operates primarily in the United States, the European Union and...

See More

Key Turning Points

3rd Resistance Point 6.80
2nd Resistance Point 6.71
1st Resistance Point 6.58
Last Price 6.44
1st Support Level 6.36
2nd Support Level 6.27
3rd Support Level 6.14

See More

52-Week High 15.00
Fibonacci 61.8% 10.74
Fibonacci 50% 9.43
Fibonacci 38.2% 8.12
Last Price 6.44
52-Week Low 3.86

See More

Want to use this as
your default charts setting?
Learn about our Custom Templates
Switch the Market flag
above for targeted data.
Open the menu and switch the
Market flag for targeted data.
Get Streaming Chart Updates
Switch your Site Preferences
to Interactive Chart
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar